5-リポオキシゲナーゼ阻害剤は分泌型ホスホリパーゼA2の神経細胞毒性を抑制する

Mammalian secretory phospholipase A2 (sPLA2) is associated with neurological diseases including brain ischemia. Previously, we have reported the contribution of arachidonate (AA) metabolites via cyclooxygenase (COX) to the neurotoxicity of sPLA2. However, it has not yet been sufficiently clarified h...

Full description

Saved in:
Bibliographic Details
Published in日本薬理学会年会要旨集 p. 3-P-205
Main Authors 矢上, 達郎, 山本, 泰弘, 高馬, 宏美
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本薬理学会 2022
Subjects
Online AccessGet full text
ISSN2435-4953
DOI10.1254/jpssuppl.95.0_3-P-205

Cover

Abstract Mammalian secretory phospholipase A2 (sPLA2) is associated with neurological diseases including brain ischemia. Previously, we have reported the contribution of arachidonate (AA) metabolites via cyclooxygenase (COX) to the neurotoxicity of sPLA2. However, it has not yet been sufficiently clarified how arachidonate metabolites via 5-lipoxygenase (LOX) is involved in the neurotoxicity of sPLA2. In the present study, we evaluated protective effects of LOX inhibitors (phenidone and AA-868) against the group IB porcine sPLA2 (sPLA2-IB) in the primary culture of rat cortical neurons. sPLA2-IB-induced neuronal apoptosis had been established as the in vitro model for cerebral ischemia. sPLA2-IB generated reactive oxygen species and triggered the influx of Ca2+ into neurons via L-type voltage-dependent calcium channel (L-VDCC). We confirmed protective effects of a radical scavenger, vitamin E, and an L-VDCC blocker, nimodipine, on the neurotoxicity of sPLA2-IB. Before neuronal cell death, the enzyme produced AA metabolites via COX and LOX, prostaglandin (PG) D2 and leukotriene (LT) B4, respectively. As well as COX inhibitors, LOX inhibitors prevented neurons from the sPLA2-IB-induced cell death. A PGD2 receptor antagonist, BWA868C, did not exhibit protective effect on the neurotoxicity of sPLA2-IB. On the other hand, receptor antagonists for LTB4 (LY293111) and cysteinyl LTs (ONO-1078) suppressed the neurotoxicity of sPLA2-IB in a concentration-dependent manner. Furthermore, these LTR blockers ameliorated morphological alterations such as shrank neuronal cell bodies and shortened neurites in the sPLA2-IB-treated neurons. Thus, the present study suggested that AA metabolites via LOX might be involved in the sPLA2-IB-induced neuronal apoptosis.
AbstractList Mammalian secretory phospholipase A2 (sPLA2) is associated with neurological diseases including brain ischemia. Previously, we have reported the contribution of arachidonate (AA) metabolites via cyclooxygenase (COX) to the neurotoxicity of sPLA2. However, it has not yet been sufficiently clarified how arachidonate metabolites via 5-lipoxygenase (LOX) is involved in the neurotoxicity of sPLA2. In the present study, we evaluated protective effects of LOX inhibitors (phenidone and AA-868) against the group IB porcine sPLA2 (sPLA2-IB) in the primary culture of rat cortical neurons. sPLA2-IB-induced neuronal apoptosis had been established as the in vitro model for cerebral ischemia. sPLA2-IB generated reactive oxygen species and triggered the influx of Ca2+ into neurons via L-type voltage-dependent calcium channel (L-VDCC). We confirmed protective effects of a radical scavenger, vitamin E, and an L-VDCC blocker, nimodipine, on the neurotoxicity of sPLA2-IB. Before neuronal cell death, the enzyme produced AA metabolites via COX and LOX, prostaglandin (PG) D2 and leukotriene (LT) B4, respectively. As well as COX inhibitors, LOX inhibitors prevented neurons from the sPLA2-IB-induced cell death. A PGD2 receptor antagonist, BWA868C, did not exhibit protective effect on the neurotoxicity of sPLA2-IB. On the other hand, receptor antagonists for LTB4 (LY293111) and cysteinyl LTs (ONO-1078) suppressed the neurotoxicity of sPLA2-IB in a concentration-dependent manner. Furthermore, these LTR blockers ameliorated morphological alterations such as shrank neuronal cell bodies and shortened neurites in the sPLA2-IB-treated neurons. Thus, the present study suggested that AA metabolites via LOX might be involved in the sPLA2-IB-induced neuronal apoptosis.
Author 山本, 泰弘
高馬, 宏美
矢上, 達郎
Author_xml – sequence: 1
  fullname: 矢上, 達郎
  organization: 姫路獨協大・薬
– sequence: 1
  fullname: 山本, 泰弘
  organization: 姫路獨協大・薬
– sequence: 1
  fullname: 高馬, 宏美
  organization: 姫路獨協大・薬
BookMark eNo9kM1KAlEAhS9RkJmP0COMzdyfce5SJCsQclHry53xTjmoyYwt2uUdCFM3uioiV0UgpJH9EPk2lxnrLUqsNt_ZnHMW3xpYrh3XBAAbhp42IMGbXj0ITur1SpqStM6QVtSgTpZAAmJENEwJWgWpICjbOsYZgolBE6BKNBUOVXij5FDJByXflHxSYVuFUyWnX5cf0WgSXdyq5jhqnceTbjToqPBayfc558PeopmFqjma3Q1mL93Z8-NnOIjH_fjsXsl-3O5FrVfVvFKysw5WXF4JROo3k-Agv7Wf29EKe9u7uWxB8yC0qAYdUXKhEJZwLCQyAkHdoqZtQUhNl9o2R65plgzbyJg6F8IQtklsXDIh5tSGLkVJkF_8ekGDHwpW98tV7p8y7jfKTkWwP1GMEqbPgViR_bj6LzhH3GceR9--H49w
ContentType Journal Article
Copyright 2022 本論文著者
Copyright_xml – notice: 2022 本論文著者
DOI 10.1254/jpssuppl.95.0_3-P-205
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2435-4953
ExternalDocumentID article_jpssuppl_95_0_95_3_P_205_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
RJT
ID FETCH-LOGICAL-j2289-2cedf2ee8ec83e7e320896b82296f9bba3f66d1b1760aee1eb65b4d624a9b2f93
IngestDate Wed Sep 03 06:30:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Japanese
LinkModel OpenURL
MeetingName 日本薬理学会年会要旨集 第95回日本薬理学会年会
MergedId FETCHMERGED-LOGICAL-j2289-2cedf2ee8ec83e7e320896b82296f9bba3f66d1b1760aee1eb65b4d624a9b2f93
Notes 95_3-P-205
OpenAccessLink https://www.jstage.jst.go.jp/article/jpssuppl/95/0/95_3-P-205/_article/-char/ja
ParticipantIDs jstage_primary_article_jpssuppl_95_0_95_3_P_205_article_char_ja
PublicationCentury 2000
PublicationDate 2022
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022
PublicationDecade 2020
PublicationTitle 日本薬理学会年会要旨集
PublicationYear 2022
Publisher 公益社団法人 日本薬理学会
Publisher_xml – name: 公益社団法人 日本薬理学会
SSID ssib044754519
ssj0003321863
ssib041654217
Score 1.8856974
Snippet Mammalian secretory phospholipase A2 (sPLA2) is associated with neurological diseases including brain ischemia. Previously, we have reported the contribution...
SourceID jstage
SourceType Publisher
StartPage 3-P-205
SubjectTerms apoptosis
leukotriene
lipoxygenase
phospholipase
Title 5-リポオキシゲナーゼ阻害剤は分泌型ホスホリパーゼA2の神経細胞毒性を抑制する
URI https://www.jstage.jst.go.jp/article/jpssuppl/95/0/95_3-P-205/_article/-char/ja
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本薬理学会年会要旨集, 2022, pp.3-P-205
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center)
  databaseCode: M~E
  dateStart: 20180101
  customDbUrl:
  isFulltext: true
  eissn: 2435-4953
  dateEnd: 99991231
  titleUrlDefault: https://road.issn.org
  omitProxy: true
  ssIdentifier: ssib044754519
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Na9RAFA-lXryIouI3PTgXJTU7yUxmTjKzZimC0kMLvYUkmz0sWIu0Fw9isyC17aU9KWJPilCwFesHYv-bYbf6X_jebLK7ag-2Qhh-vLx57817SWbeMDNxnOsezzOZ0MD1Mpm5QdgMXJGFuNa1lQRengd5jonivft8aja4O8fmxsZvjKxaWlpMJ7PHh-4rOU5UgQZxxV2yR4jsQCgQAEN8oYQIQ_lPMWYuiXwifKJUCeQdC2hFAVBRdFgBWjKLqpauV7cASCIF0ZpEjKiIaB-BkEQFlqdGVMNSBBGcRBwZRB0pMiJCV2boSqD8nTJqau1v7YpWSiIShURZqQA0s0oABER7JBJWQIT6wRxJEQiPqKqJJUVZJdZYzUvJUpY8Qo8OzJFfWo0I6kTVUYvkFoREera5DN2pAARotVRIgSaCVUOKQAZQVAoU1qOaiMEUqJXXINhWqCTQTHjOkQ3NCywAC6MhPyip4TUwzfJb36M3mFUthvwQLY1RRMAH_DaeomHdGFXyywkfOpwYsA5jVbu1fUpCDD9UwjBrovxSuWS2CQqum8dzYH98YDsiCkNqF9chj3R0vjsNryI7tBOmLMBOeAE-HJBJTUo26cUj_H-cb16-PXHFH0sWe1j48XQMVeKKAbchxm3IhU7QEEaVuEz3SVT1HQHuyqPDVB3PscSTkwbzrb6Pf1_zy018YOKtQw2EgWgb0rJqSacdZc6cdk6V6eGE6htzxhlrJ2edB8w1nW3TeW2KbVO8N8VXU3w0nVXT2TfF_s8X37s7e93nb8zybnflWW9vvbu1ZjqvTPENS6y40edU1CzvHLzdOvi8fvDpw4_OVm93s_f0nSk2e6sb3ZUvZvmlKdbOObONaKY-5Za_SXHblOIaxSxvtmieizwTfh7mPvWE5Cn-yYG3ZJomfovzZi2thdxL4NObp5ylQZPTIJEpbUn_vDM-_3A-v-BMNCFB4SITaUgzcGAia4y3eIvRJK2lkNlcdG73vRMv9M_CiY8avUv_LeGycxLfiv406BVnfPHRUn4VEoPF9Jp9In4BDmzhuQ
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=5-%E3%83%AA%E3%83%9D%E3%82%AA%E3%82%AD%E3%82%B7%E3%82%B2%E3%83%8A%E3%83%BC%E3%82%BC%E9%98%BB%E5%AE%B3%E5%89%A4%E3%81%AF%E5%88%86%E6%B3%8C%E5%9E%8B%E3%83%9B%E3%82%B9%E3%83%9B%E3%83%AA%E3%83%91%E3%83%BC%E3%82%BCA2%E3%81%AE%E7%A5%9E%E7%B5%8C%E7%B4%B0%E8%83%9E%E6%AF%92%E6%80%A7%E3%82%92%E6%8A%91%E5%88%B6%E3%81%99%E3%82%8B&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%96%AC%E7%90%86%E5%AD%A6%E4%BC%9A%E5%B9%B4%E4%BC%9A%E8%A6%81%E6%97%A8%E9%9B%86&rft.au=%E7%9F%A2%E4%B8%8A%2C+%E9%81%94%E9%83%8E&rft.au=%E5%B1%B1%E6%9C%AC%2C+%E6%B3%B0%E5%BC%98&rft.au=%E9%AB%98%E9%A6%AC%2C+%E5%AE%8F%E7%BE%8E&rft.date=2022&rft.pub=%E5%85%AC%E7%9B%8A%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%96%AC%E7%90%86%E5%AD%A6%E4%BC%9A&rft.eissn=2435-4953&rft.spage=3-P-205&rft_id=info:doi/10.1254%2Fjpssuppl.95.0_3-P-205&rft.externalDocID=article_jpssuppl_95_0_95_3_P_205_article_char_ja